GF deepens its engagement with the startup ecosystem, partnering with experienced technology leaders to support next wave of AI data center and Physical AI technologies MALTA, N.Y., May 19, 2026 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) (GF) today announced that it is investing in Playground Global’s Fund IV as a limited partner through GF Accelerate, formalizing GF’s expanding commitment to early-stage deep tech startups tackling the world’s hardest problems. This investment extends GF’s work with leading technology-focused venture platforms and reflects the company’s strategy of aligning long-term capital with real-world technology, engineering and manufacturing expertise. GF’s participation builds on its broader engagement with early-stage partners across regions, including collaborations designed to advance differentiated,...

Commercial milestone marks Seegnal’s first engagement in the United States, advancing the Company’s commercial expansion strategy; Pilot expected to begin shortly CALGARY, AB, May 19, 2026 (GLOBE NEWSWIRE) — Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today announced that it has entered into a letter of intent (the “LOI”), dated May 5, 2026, with a U.S.-based long-term care provider to conduct a pilot program with Seegnal’s clinical decision support platform. The LOI marks Seegnal’s first pilot engagement in the United States. Under the LOI, the parties intend to conduct a pilot program during which Seegnal’s platform will analyze prescription data without affecting...

WILMINGTON, Del., May 19, 2026 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company, today announced that the company has signed a new IoT patent license agreement with a fintech company in the payments space. The agreement covers the licensee’s point-of-sale devices under InterDigital’s global patent portfolio related to the cellular 3G and 4G standards, and the Wi-Fi 5 and Wi-Fi 6 standards. “This agreement is another demonstration of the momentum we’re building across the IoT space,” commented Julia Mattis, Chief Licensing Officer, InterDigital. “This company is a widely recognized disruptor in the fintech sector and we’re glad that it recognizes the value our wireless technology brings to its business.” About InterDigital® InterDigital is a global research...

Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed at UCSD HOUSTON, TX, May 19, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. ( (Nasdaq: NXL) (“Nexalin” or the “Company”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the closing of its acquisition of PONM, Inc. (“PONM”) from GreenLight Ventures, LLC (“GreenLight”). PONM is the digital health platform supporting Nexalin’s HALO™ Clarity program and Nexalin NeuroCare™ virtual clinic. Through the transaction, Nexalin has secured ownership of PONM and an exclusive license to the proprietary software features developed for the HALO™ program, including AI-integrated remote patient monitoring, treatment-compliance...

NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will be participating in the Jefferies Global Healthcare Conference. Chairman and CEO David Hochman will participate in a fireside chat with Matt Taylor, Managing Director at Jefferies at 9:55am ET on Thursday June 4, 2026 and will also host one-on-one meetings with investors that day and on Wednesday, June 3. The fireside chat will be accessible to investors and interested parties via a live webcast, which is available on Orchestra BioMed’s Investor Relations website. About Orchestra BioMedOrchestra BioMed is a biomedical innovation company accelerating...

CHESTERBROOK, Pa., May 19, 2026 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced that William M. Clancy, its Executive Vice President and Chief Financial Officer, will be retiring effective December 31, 2026, and that the Company’s Board of Directors will be conducting a search for his successor. Through his 38-year career at VPG and its predecessor company, Mr. Clancy has served in a variety of senior financial leadership roles throughout his tenure. Among his many accomplishments, he played a key leadership role in the successful creation of VPG as an independent publicly traded company, helping to establish a strong financial foundation and positioning the organization for long-term success. “On behalf of the Board of Directors and the entire...

Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall Patent strengthens intellectual property foundation for next-generation neuromodulation technologies THE WOODLANDS, TX, May 19, 2026 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,544,131 (the “131 patent”), titled “Systems, Methods, and Devices for Monitoring and Treatment of Tissues Within And/Or Through a Lumen Wall.” The newly issued patent strengthens the Company’s growing global intellectual property portfolio, which includes issued and pending patent applications covering foundational...

Agreement follows Cibolo Health’s endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences’ ECG management platform Southlake, TX, May 19, 2026 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that it has entered into a commercial agreement with North Shore Health, a community hospital serving Cook County, Minnesota and the surrounding region, to deploy the MyoVista Insights™ platform. North Shore Health is part of the Cibolo Rural Health Networks (“Cibolo Health”) network, which previously selected MyoVista Insights...

MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, today announced that Chief Executive Officer Shaun Bagai and Chief Financial Officer Mark Voll will participate in the Alliance Global Partners (AGP) Annual Healthcare Company Showcase, hosted by Scott Henry, AGP’s Managing Director and Senior Healthcare Analyst, on May 20, 2026. Mr. Bagai and Mr. Voll will discuss RenovoRx’s commercial progress, including record first-quarter 2026 revenue from RenovoCath as a standalone drug-delivery device, accelerating RenovoCath adoption at high-volume cancer centers, and growing repeat orders. They will also highlight the Company’s...

Dubai, UAE, May 19, 2026 (GLOBE NEWSWIRE) — Micropolis AI Robotics (NYSE American: MCRP) today announced that it received a notice from NYSE Regulation on May 18, 2026 indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (“NYSE American” or the “Exchange”). The Company failed to timely file its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the “2025 Form 20-F”) by the filing due date of May 15, 2026 (the “Filing Delinquency”). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide. NYSE Regulation notified the Company that NYSE American will closely monitor the status of the Company’s 2025 Form 20-F and any subsequent delayed filings for a six-month period from the date of the Filing...